- Modified Release Tacrolimus
-
First MR, Fitzsimmons WE
- KMID: 1726178
- Yonsei Med J.
- 2004 Dec;45(6):1127-1131.
- doi: 10.3349/ymj.2004.45.6.1127
Modified Release (MR) tacrolimus is an extended release formulation of tacrolimus (Prograf (R) ) administered once daily in the morning. In healthy volunteers, the MR tacrolimus formulation given qd AM... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes of Antimicrobial Peptides and Transepidermal Water Loss After Topical Application of Tacrolimus and Ceramide-dominant Emollient in Patients with Atopic Dermatitis
-
Park KY, Kim DH, Jeong MS, Li K, Seo SJ
- KMID: 1713963
- J Korean Med Sci.
- 2010 May;25(5):766-771.
- doi: 10.3346/jkms.2010.25.5.766
Increased transepidermal water loss (TEWL) and downregulated antimicrobial peptides (AMPs) are observed in patients with atopic dermatitis (AD). Tacrolimus and ceramide-dominant emollients are effective in the treatment of AD by... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety and Efficacy of Conversion from Twice-Daily Tacrolimus to Once-Daily Tacrolimus One Month after Transplantation: Randomized Controlled Trial in Adult Renal Transplantation
-
Oh CK, Huh KH, Lee JS, Cho HR, Kim YS
- KMID: 1799500
- Yonsei Med J.
- 2014 Sep;55(5):1341-1347.
- doi: 10.3349/ymj.2014.55.5.1341
PURPOSE: The purpose of this study was to compare once-daily tacrolimus with twice-daily tacrolimus in terms of safety, efficacy, and patient satisfaction. MATERIALS AND METHODS: This prospective, randomized, open-label, multicenter study... -
- CITED
-
- Close
- SHARE
-
- Close
- A 12-Month Single Arm Pilot Study to Evaluate the Efficacy and Safety of Sirolimus in Combination with Tacrolimus in Kidney Transplant Recipients at High Immunologic Risk
-
Lee J, Lee JJ, Kim BS, Lee JG, Huh KH, Park Y, Kim YS
- KMID: 2160593
- J Korean Med Sci.
- 2015 Jun;30(6):682-687.
- doi: 10.3346/jkms.2015.30.6.682
The optimal immunosuppressive strategy for renal transplant recipients at high immunologic risk remains a topic of investigation. This prospective single arm pilot study was undertaken to evaluate the safety and... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Effect of 0.03% Tacrolimus Ointment for Ocular Graft versus Host Disease and Vernal Keratoconjunctivitis
-
Ryu EH, Kim JM, Laddha PM, Chung ES, Chung TY
- KMID: 1387389
- Korean J Ophthalmol.
- 2012 Aug;26(4):241-247.
- doi: 10.3341/kjo.2012.26.4.241
PURPOSE: To determine whether topical tacrolimus might prove effective in the treatment of refractory anterior segment inflammatory diseases, and to evaluate its efficacy in eyes with ocular graft versus host... -
- CITED
-
- Close
- SHARE
-
- Close
- Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients in Korea
-
Lee JH, Lee SK, Lee HJ, Seo JM, Joh JW, Kim SJ, Kwon CH, Choe YH
- KMID: 1777091
- Yonsei Med J.
- 2009 Dec;50(6):784-788.
- doi: 10.3349/ymj.2009.50.6.784
PURPOSE: We identified pediatric liver transplant recipients with successful withdrawal of immunosuppression who developed tolerance in Korea. MATERIALS AND METHODS: Among 105 pediatric patients who received liver transplantation and were treated... -
- CITED
-
- Close
- SHARE
-
- Close
